Roflumilast for asthma: Weighing the evidence

被引:5
|
作者
Bateman, E. D. [1 ]
O'Byrne, P. M. [2 ]
Buhl, R. [3 ]
Rabe, K. F. [4 ,5 ]
机构
[1] Univ Cape Town, Lung Inst, Dept Med, Div Pulmonol, ZA-7925 Cape Town, South Africa
[2] McMaster Univ, Firestone Inst Resp Hlth, Dept Med, Hamilton, ON L8S 4L8, Canada
[3] Mainz Univ Hosp, Dept Pulm, Mainz, Germany
[4] LungClin, Grosshansdorf, Germany
[5] Univ Kiel, Dept Med, Kiel, Germany
关键词
Asthma; Roflumilast; Safety; Placebo; FEV1; ICS; OBSTRUCTIVE PULMONARY-DISEASE; PDE4 INHIBITOR ROFLUMILAST; RANDOMIZED CLINICAL-TRIALS; PHOSPHODIESTERASE-4; INHIBITOR; SPUTUM; BRONCHODILATORS; INFLAMMATION; EFFICACY; UPDATE;
D O I
10.1016/j.pupt.2015.08.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S1 / S3
页数:3
相关论文
共 50 条
  • [21] IN THE BALANCE - WEIGHING THE EVIDENCE
    HUTH, EJ
    ANNALS OF INTERNAL MEDICINE, 1994, 120 (10) : 889 - 889
  • [22] Weighing and communicating evidence
    不详
    NATURE BIOTECHNOLOGY, 2020, 38 (08) : 903 - 903
  • [23] Weighing up the evidence
    Heidi Ledford
    Nature, 2007, 447 : 512 - 513
  • [24] Weighing up the evidence
    Waterson, Patrick
    POLICY AND PRACTICE IN HEALTH AND SAFETY, 2018, 16 (02) : 155 - 157
  • [25] Effect of roflumilast on airway remodeling in a murine model of chronic asthma
    Kim, Sei Won
    Rhee, Chin Kook
    Kim, Jin Woo
    Lee, Sook Young
    Ahn, Joong Hyun
    Yoon, Hyoung Kyu
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [26] Effect of roflumilast on airway remodelling in a murine model of chronic asthma
    Kim, S. W.
    Kim, J. H.
    Park, C. K.
    Kim, T. J.
    Lee, S. Y.
    Kim, Y. K.
    Kwon, S. S.
    Rhee, C. K.
    Yoon, H. K.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2016, 46 (05): : 754 - 763
  • [27] Roflumilast for asthma: Efficacy findings in placebo-controlled studies
    Meltzer, E. O.
    Chervinsky, P.
    Busse, W.
    Ohta, K.
    Bardin, P.
    Bredenbroeker, D.
    Bateman, E. D.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 35 : S20 - S27
  • [28] EFFECT OF ROFLUMILAST ON AIRWAY REMODELING IN A MURINE MODEL OF CHRONIC ASTHMA
    Lee, H. Y.
    Rhee, C. K. R.
    Lee, H. Y. L.
    Kang, J. Y. K.
    Lee, S. Y. L.
    Kim, Y. K. K.
    Kwon, S. S. K.
    Yoon, H. Y.
    RESPIROLOGY, 2014, 19 : 63 - 63
  • [29] Synergistic effect of roflumilast with dexamethasone in a neutrophilic asthma mouse model
    Park, Chan Kwon
    An, Tai Joon
    Kim, Ji Hye
    Rhee, Chin Kook
    Yoon, Hyoung Kyu
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (06) : 624 - 632
  • [30] In Vivo Evidence Of Cftr Activation By Roflumilast: A Potential Mechanism Underlying Therapeutic Benefit Of Roflumilast In COPD
    Raju, S.
    Tang, L.
    Rowe, S. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189